Elizabeth Warren (Michael Brochstein/Sipa USA)(Sipa via AP Images)
January 31, 2022 02:14 PM ESTUpdated February 1, 08:24 AM
Pharma
FDA+

In pledg­ing to vote for Rob Califf, Eliz­a­beth War­ren takes a swing at the FDA-in­dus­try re­volv­ing door

Zachary Brennan

Senior Editor

At this point, Rob Califf is do­ing what­ev­er he can to nab votes from Re­pub­li­cans or even De­moc­rats.

While mem­bers of both par­ties his­tor­i­cal­ly fall …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

You bet your life: Af­ter I was di­ag­nosed with a rare can­cer, I dis­cov­ered how a small band of physi­cian-sci­en­tists ...

A VC-backed ge­net­ic test­ing start­up to 'con­sid­er' mak­ing an of­fer to buy 23andMe

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

No­vo says its CB1 drug helped shed weight, but ef­fi­ca­cy and safe­ty ques­tions re­main

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times